Work

Abstract PS1-11-30: Implications of PIK3CA/HER2 Status and Age/Comorbidities on Clinical Investigators’ (CIs) Selection of First-Line Systemic Therapy for Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC)

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-11-30

Authors: K. H. Pang, J. O’Shaughnessy, V. Kaklamani, G. Kelly, T. Wallace, T. Cruse, K. Miller, K. A. Ziel, D. Paley, N. Love

Institutions: Baylor University Medical Center, The University of Texas at San Antonio Health Science Center

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129519825

Cites:

Cited by:

Related to: